Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one ...

Inogen has continued to struggle, with growth in the rental business overshadowed by declines in direct-to-consumer sales, volatility in business-to-business sales, and pricing pressures. Inogen has ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of its high prospects in the portable oxygen concentrator (POC) space. The optimism led by solid second-quarter 2023 and a ...

Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter and the full year ended December ...

Developed in collaboration with Yuwell Medical, Voxi 5 presents a viable option for patients seeking reliable stationary oxygen therapy, delivering 1-5 L/min of quiet1, pure2, continuous flow oxygen ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results ...

Medical Technology company Inogen Inc (NASDAQ:INGN) reported a fourth-quarter adjusted EPS loss of 24 cents, compared to a loss of 83 cents a year ago, beating the consensus loss of 61 cents. The ...

This article first appeared on GuruFocus. Inogen Inc (NASDAQ:INGN) is set to release its Q3 2025 earnings on Nov 5, 2025. The consensus estimate for Q3 2025 revenue is $92.20 million, and the earnings ...

Long term investing works well, but it doesn't always work for each individual stock. We don't wish catastrophic capital loss on anyone. Imagine if you held Inogen, Inc. (NASDAQ:INGN) for half a ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that its Board of ...